[1]
Eiras, I., Magalhães, I. and Martins, S. 2026. Glucagon-like peptide-1 analog in the treatment of metabolic dysfunction-associated steatotic liver disease. International Journal of Contemporary Pediatrics. 13, 9 (Aug. 2026), 1841–1843. DOI:https://doi.org/10.18203/2349-3291.ijcp20262978.